This Biotech Stock 135% Jump Trims $44M: What Now Today
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
When priorities drift, budgets fray and goals slip away. This intro shows how aligning spending with goals reduces chaos and builds stability.
22,744 articlesA biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Bitcoin and XRP led a crypto rally after a Trump Iran-focused post, with BTC moving higher and XRP testing multi-week...
As AI expands from novelty to durable demand, investors wonder if the AI trade is entering its second wave. This arti...
AST SpaceMobile targets a dramatic rise in value as it scales its satellite network and carrier partnerships, but pro...
Shoppers beware: discounts arrive in predictable waves after cart abandonment, but the timing varies by category. Her...
TIAA’s CEO argues that leaders should rent the title, not own it, and invest in character traits that endure beyond a...
Investors woke up to a modest rally in Intel as executives highlighted strong demand and expansion plans. This articl...
Deciding when to start Social Security can dramatically change retirement income. Learn how to assess your situation ...
IonQ delivers a standout Q1 and a fresh price-target outlook that signals potential triple-digit gains over the next ...
The first-quarter earnings season is more than a quarterly ritual. It’s a blueprint for 2026, showing how AI investme...
SpaceX has landed a historic IPO. This article lays out a 180-day plan for investors, with key dates, valuations, and...
A CEO’s dramatic pledge to fire anyone who won’t adopt AI highlights the tension between automation and the evolving ...